These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 11382591

  • 1. The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors.
    Neufeld G, Kessler O, Vadasz Z, Gluzman-Poltorak Z.
    Surg Oncol Clin N Am; 2001 Apr; 10(2):339-56, ix. PubMed ID: 11382591
    [Abstract] [Full Text] [Related]

  • 2. [Tumor progression and angiogenesis].
    Maru Y.
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1509-19. PubMed ID: 10500543
    [Abstract] [Full Text] [Related]

  • 3. Tumoral vascularity as a prognostic factor in cancer.
    Weidner N, Folkman J.
    Important Adv Oncol; 1996 Sep; ():167-90. PubMed ID: 8791135
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K.
    Cancer Res; 2000 Jan 15; 60(2):203-12. PubMed ID: 10667560
    [No Abstract] [Full Text] [Related]

  • 5. [Vascular endothelial growth factor. From basic research to clinical application].
    Smirne C, Camandona M, Rosso E, Bellone G, Emanuelli G.
    Minerva Med; 1999 Jan 15; 90(1-2):15-23. PubMed ID: 10388459
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C, Ortega N, Bayard F, Plouet J.
    Diabetes Metab; 1996 Jul 15; 22(4):268-73. PubMed ID: 8767174
    [Abstract] [Full Text] [Related]

  • 7. [The hypoxia-inducible factor HIF as a new target in cancer research].
    L'Allemain G.
    Bull Cancer; 2002 Mar 15; 89(3):257-60. PubMed ID: 11940464
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 9. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F, Tian YH, Li L, Chen XF, Hu HH, Li CY, Huang Q.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar 15; 34(2):165-70. PubMed ID: 12006990
    [Abstract] [Full Text] [Related]

  • 10. New developments in angiogenesis: a major mechanism for tumor growth and target for therapy.
    Jones A, Harris AL.
    Cancer J Sci Am; 1998 Mar 15; 4(4):209-17. PubMed ID: 9689977
    [No Abstract] [Full Text] [Related]

  • 11. Angiogenesis and vascular endothelial growth factor (VEGF): is it relevant in renal patients?
    Gröne HJ.
    Nephrol Dial Transplant; 1995 Mar 15; 10(6):761-3. PubMed ID: 7566598
    [No Abstract] [Full Text] [Related]

  • 12. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.
    Cancer Res; 2002 Feb 01; 62(3):854-9. PubMed ID: 11830543
    [Abstract] [Full Text] [Related]

  • 13. [Angiogenesis and inhibition of angiogenesis in the eye].
    Cursiefen C, Schönherr U.
    Klin Monbl Augenheilkd; 1997 Jun 01; 210(6):341-51. PubMed ID: 9333658
    [Abstract] [Full Text] [Related]

  • 14. [Role of angiogenesis in lung cancer and its metastases].
    Yano S, Sone S.
    Gan To Kagaku Ryoho; 1999 Dec 01; 26(14):2131-8. PubMed ID: 10635295
    [Abstract] [Full Text] [Related]

  • 15. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA, Paavonen K.
    Microsc Res Tech; 2001 Oct 15; 55(2):108-21. PubMed ID: 11596156
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC, Zielke A.
    Exp Clin Endocrinol Diabetes; 2002 Nov 15; 110(8):386-92. PubMed ID: 12518248
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I.
    IDrugs; 2003 Mar 15; 6(3):224-31. PubMed ID: 12789611
    [Abstract] [Full Text] [Related]

  • 18. [Tumor angiogenesis].
    Bussolino F.
    Recenti Prog Med; 1999 Jan 15; 90(1):28-36. PubMed ID: 10193163
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 20. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
    Davidoff AM, Nathwani AC, Spurbeck WW, Ng CY, Zhou J, Vanin EF.
    Cancer Res; 2002 Jun 01; 62(11):3077-83. PubMed ID: 12036917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.